A molecular "silencer" makes leukemia cells invisible
The discovery paves the way for new treatments of AML relapses post transplantation
MOREPromising preclinical results for TCR T-cells in AML
The first clinical trial in AML patients, sponsored by Intellia Therapeutics, already began in UK and USA
MORERemoving cancer "sugar shield" improves CAR T efficacy
The layer of sugars surrounding cancer cells plays a key role in protecting them from the immune system
MOREHighlights
The first neutrophil atlas
A research team from SR-Tiget generated for the first time a complete mapping of human...
A new gene therapy platform for glioblastoma multiforme
A group of researchers at San Raffaele in Milan developed a gene therapy strategy able to...
New steps towards the development of artificial lymph nodes
Researchers have reconstructed, for the first time, the progenitors of the lymph nodes cells....
Research Highlights
Great research leads to great results. Our pioneering science in numbers.
Research integrity
Upholding high standards of quality, trustworthiness and reproducibility
Industry collaborations
Join the excellence. Explore our integrated biomedical innovation pipeline.
Science outreach
Bridging the gap between science and society, for the benefit of both.